美股A股
StockGist
Back
8-K2026-03-27· deepseek-chat

TIL · Instil Bio, Inc.

0001789769-26-000018

SEC filing

Summary

Instil Bio reported its fourth quarter and full year 2025 financial results, including a net loss per share of $1.21 for Q4 2025 and $10.70 for the full year, and announced a strategic shift to focus on potential acquisitions and in-licensing opportunities. The company's cash position of $76.3 million as of December 31, 2025 is expected to fund its current operating plan beyond 2027.

Key takeaways